J Kolanowski

Summary

Country: Belgium

Publications

  1. ncbi request reprint A risk-benefit assessment of anti-obesity drugs
    J Kolanowski
    Endocrine Unit, Catholic University of Louvain, Brussels, Belgium
    Drug Saf 20:119-31. 1999

Detail Information

Publications1

  1. ncbi request reprint A risk-benefit assessment of anti-obesity drugs
    J Kolanowski
    Endocrine Unit, Catholic University of Louvain, Brussels, Belgium
    Drug Saf 20:119-31. 1999
    ..Such a treatment is not available at present. Development of new agents and a more careful assessment of the safety of currently available drugs are needed...